Cargando…
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
BACKGROUND/PURPOSE: This study aims to quantify the utility of monitoring LVEF, hs-cTnT, and NT-proBNP for dynamic cardiotoxicity risk assessment in women with HER2+ early breast cancer undergoing neoadjuvant/adjuvant trastuzumab-based therapy. MATERIALS AND METHODS: We used joint models of longitud...
Autores principales: | Posch, Florian, Niedrist, Tobias, Glantschnig, Theresa, Firla, Saskia, Moik, Florian, Kolesnik, Ewald, Wallner, Markus, Verheyen, Nicolas, Jost, Philipp J., Zirlik, Andreas, Pichler, Martin, Balic, Marija, Rainer, Peter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424929/ https://www.ncbi.nlm.nih.gov/pubmed/36051281 http://dx.doi.org/10.3389/fcvm.2022.933428 |
Ejemplares similares
-
Cohort profile: ‘Biomarkers of Personalised Medicine’ (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases
por: Haudum, Christoph Walter, et al.
Publicado: (2022) -
Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022) -
Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021) -
Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021) -
Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data Analysis
por: Gressenberger, Paul, et al.
Publicado: (2022)